Figure 4.

PRM_rCBV of a patient nonresponsive to therapy with an overall survival of 2.9 months. Representative slice of PRM_rCBV color-coded VOI (A, C: Gd-VOI and B, D: FLAIR-VOI) superimposed onto an rCBV map (left) and the corresponding quantitative scatterplot analysis (right) showing the distribution or rCBV at baseline compared with mid-time treatment (A, B: week 1 and C, D: week 3). For each scatterplot, the values of PRM_rCBV+, PRM_rCBV0, and PRM_rCBV- of this patient (corresponding to the relative tumor volume of red, green, and blue voxel pairs plotted as dots, respectively) are presented.